Prenatal Exposures and Experiences: Impact on Children’s Early Brain Development and Risk for Disease
January 10, 2022 08:00 ET
|
Brain & Behavior Research Foundation
New York, Jan. 10, 2022 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Prenatal Exposures and Experiences: Impact on Children’s Early Brain...
Nexstim Receives Order for Two NBT® Systems from Finnish University Hospital Customer
December 10, 2021 02:00 ET
|
Nexstim Oyj
Press release, Helsinki, December 10, 2021 at 9 AM (EET) Nexstim Receives Order for Two NBT® Systems from Finnish University Hospital Customer Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or...
OCD: Using Genome Data to Predict Risk, Symptoms and Treatment Response - A Free Webinar from the Brain & Behavior Research Foundation
December 07, 2021 09:00 ET
|
Brain & Behavior Research Foundation
New York, Dec. 07, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “OCD: Using Genome Data to Predict Risk, Symptoms and Treatment Response”...
OWP Pharmaceuticals Announces IND Authorization for the First-Ever Oral Liquid Formulation of Atomoxetine Hydrochloride for the Treatment of Attention Deficit Hyperactivity Disorder
November 17, 2021 08:00 ET
|
OWP Pharmaceuticals, Inc.
NAPERVILLE, Ill., Nov. 17, 2021 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc. is a privately held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and...
Nexstim aloittaa yhteistyön suomalaisen yksityisklinikan kanssa ja etenee strategisissa tavoitteissaan
November 05, 2021 03:00 ET
|
Nexstim Oyj
Lehdistötiedote, Helsinki, 5.11.2021 klo 9.00 (EET) Nexstim aloittaa yhteistyön suomalaisen yksityisklinikan kanssa ja etenee strategisissa tavoitteissaan Nexstim Oyj (NXTMH:HEX, NXTMS:STO)...
Nexstim engages in cooperation with private Finnish clinic and makes progress in its strategic goals
November 05, 2021 03:00 ET
|
Nexstim Oyj
Press release, Helsinki, 5 November 2021 at 9 AM (EET) Nexstim engages in cooperation with private Finnish clinic and makes progress in its strategic goals Nexstim Plc (NXTMH:HEX, NXTMS:STO)...
Developing New Treatments for Mania Using Brain-Based Risk Markers - A Free Webinar from the Brain & Behavior Research Foundation
November 04, 2021 08:59 ET
|
Brain & Behavior Research Foundation
New York, Nov. 04, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Developing New Treatments for Mania Using Brain-Based Risk Markers” on...
Nexstim Releases the New NBS5+ in the United States
October 22, 2021 02:00 ET
|
Nexstim Oyj
Press release, Helsinki, 22 October 2021 at 9 AM (EEST) Nexstim Releases the New NBS5+ in the United States Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces the launch of a new...
Early-Life Risk for Pathological Anxiety - A Free Webinar from the Brain & Behavior Research Foundation
October 07, 2021 09:09 ET
|
Brain & Behavior Research Foundation
New York, Oct. 07, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Early-Life Risk for Pathological Anxiety” on Tuesday, October 12, 2021,...
Brain & Behavior Research Foundation Awards Over $10.3 Million In Young Investigator Grants to 150 Mental Health Scientists
October 06, 2021 09:00 ET
|
Brain & Behavior Research Foundation
New York, Oct. 06, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation today announced its annual Young Investigator Grants, valued at more than $10.3 million, awarded to 150 of...